Contact Us
Menu
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Events
News
Posts
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Events
News
Posts

Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy

Home News & Resources Publications Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy

Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy

Read entire article

Share:

Search
Back to top